On the recordJanuary 7, 2020
Extending immunosuppressive drug coverage for the lifetime of kidney patients is a cost-effective way for the Federal Government to improve clinical outcomes for those with end-stage renal disease.
Source
congress.govEditor's note · Context
Walden advocates for lifetime coverage of immunosuppressive drugs for kidney patients to improve outcomes.
Share
More from Greg Walden
Dec 9, 2020
I thank the gentlewoman from Michigan for her kind comments and her leadership on this legislation. Mr. Speaker, can I inquire how much time is remaining? The SPEAKER pro tempore. The gentleman from Oregon has 11\1/2\ minutes remaining.
Nov 17, 2020
I want to thank the gentlewoman from Delaware, my friend, for her work on this and so many other pieces of legislation and our work together. We have had a good run. There is still more work to be done in the next 40-some days, but I thank…
Dec 9, 2020
To thank my dear friend and colleague, Mr. Olson, who we all know, it turns out, is from Texas 22; and his wife, Nancy. I wish them the very best in their lives ahead. Mr. Speaker, since he is talking about a little history, I want to talk…
Mar 10, 2023
The FCC Process Reform Act is bipartisan legislation that passed the House on March 11 of this year and would bring needed reforms to the commission's processes.
Other voices in this conversation
